Abstract

Unused pharmaceutical compounds (PhCs) discharged into the aquatic environment have been regarded as emerging pollutants due to potential harmful effects on humans and the environment. Microbial bioremediation is considered as a viable option for their removal from wastewater. The aim of this study was to assess the simultaneous removal of carbamazepine (CBZ), diclofenac (DCF) and ibuprofen (IBP) by previously isolated fungi (Aspergillus niger, Mucor circinelloides, Trichoderma longibrachiatum, Trametes polyzona, and Rhizopus microsporus). The tolerance to PhCs was conducted by tracking the fungal mycelium mat diameters in solid media and its dry biomass in liquid media, at the drug concentration range of 0.1 to 15 mg/L. The fungal enzymatic activities were determined for lignin peroxidase (LiP), manganese peroxidase (MnP) and laccase (Lac), respectively. The PhC removal efficiency of the fungi was assessed in aerated batch flasks and the drug concentrations and intermediate compounds formation were determined by using SPE-UPLC/MS. A tolerance over 70% was recorded for all the fungi at drug concentration of 0.1 mg/L. Manganese peroxidase was produced by all the fungi with very low amount of LiP, while all the enzymes were produced by T. polyzona. The pH of 4.3, temperature 37 ± 1.5°C and incubation time of 6 days were the optimum parameters for the fungal enzymatic activities. The best removal of CBZ (87%) was achieved by R. microsporus after 10 days. Between 78 and 100% removal of DCF was observed by all the fungi after 24 h, while 98% of IBP was removed after 2 days by M. circinelloides. Only a few intermediate compounds were identified after 3 days and disappeared after 10 days of incubation. This study demonstrated that apart from the basidiomycetes, the ascomycetes and zygomycetes are also producers of ligninolytic enzymes and have the ability to biodegrade emerging pollutants such as PhCs.

Highlights

  • Thousands of tons of pharmaceutical compounds (PhCs) are annually consumed around the world and residues are discharged with their metabolites into the environment from households, farms, hospitals and pharmaceutical industries (Gadipelly et al, 2014; Ali et al, 2018)

  • The fungal tolerance index to PhCs in solid media or suspended in liquid media performed in indicator plates or in aerated batch flasks (ABFs) are shown in Figures 2, 3

  • DCF results in the present study revealed that, suggested intermediates could be identified at very low amount at day 3 in all the test flasks, none of them was visible at day 10, when the DCF concentration was found below the limit of quantification

Read more

Summary

Introduction

Thousands of tons of pharmaceutical compounds (PhCs) are annually consumed around the world and residues are discharged with their metabolites into the environment from households, farms, hospitals and pharmaceutical industries (Gadipelly et al, 2014; Ali et al, 2018). These synthetic compounds have complex and aromatic structures, most exhibit abilities to undergo. CBZ, DCF, and IBP are amongst the PhCs, which are known to be resistant to biodegradation (Marco-Urrea et al, 2009; Kruglova et al, 2014; Hai et al, 2018)

Objectives
Methods
Results
Discussion
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.